What Teladoc’s recent financial news may mean for companies looking for a faster entry into this $700B market?
Teladoc has been a leader in remote consumer and patient health access for two decades.
Crypto or biotech – Both are high risk and high reward investments. Bob Teague, MD layouts out the pros and cons for investors battered by market uncertainty.
A closer look at the funding vehicles driving the VC-backed health tech and biotech markets and the pitfalls for the average investor entering 2022
We know that the US health market is different, peculiar by world standards, and incomprehensibly complex. We know that it is difficult to understand as a market because the person receiving the care is not the same person directly paying for care. We have government regulation but the means of delivery are not owned by the government.
A look back on the year that was for the healthcare industry and peek ahead for the digital health market in 2022 as we enter year three of Covid-19.
Bob Teague, MD examines the history of employer driven, class-based healthcare as part of his ongoing series on the nature of the US healthcare market.
A growing direct-to-care marketplace requires the industry to stay on its toes.
Funding announcements in health innovation have been coming in hot and fast these days. It’s easy to lose perspective about where we’ve come from and where we’re going. This 2021 midyear StartUp Health Insights Report (something we’ve been doing for a decade) is an essential opportunity to step back, take a beat, and view the market with a longer lens. What’s the 10,000-foot view? We also take this opportunity to look at funding trends from a health moonshot perspective. Are we investing in the tools and services that will increase access to care, cure disease, lower cost, and achieve the other global goals that can improve the lives of billions of people? Let’s look at the numbers.
by Bob Teague
Let’s say you have the most amazing technical solution for healthcare in history.
Providing broad access to virtual care seems like an obvious thing to do. And it looks like CMS is at least considering this expansion. The Cartel is mighty, however, and the pushback could be great. The market seems to agree and is not very enthusiastic at the prospects of these firms.
PO Box 637
Austin, Texas
[email protected]
By providing your contact information you consent to receiving emails & information from Green Room Technologies.
No Spam. We respect your privacy & you may unsubscribe at any time.
